Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia

  • by

Initial pre-purchase of 10 million doses of oral vaccines with a potential deal for further orders worth hundreds of millions of dollars Prospective patient population of approximately 660 million throughout the Association of Southeast Asian Nations NEW YORK, Dec. 29, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP)… Read More »Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia

Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa

  • by

Oravax’s oral vaccine targets three surface proteins, making it potentially more effective against current and future variants Oravax’s oral vaccine should offer critical advantages, including logistics, distribution and delivery in less vaccinated regions, including Africa NEW YORK, Dec. 14, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com),… Read More »Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa

Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America

  • by

– Millions of people in the region could benefit from the COVID-19 vaccine candidate- faster, easier, without the cold chain: The Oravax Oral Vaccine – The new partnership builds on the respective strengths of Oravax Medical and Genomma Lab to create compelling value for both companies and their… Read More »Oramed Subsidiary Oravax Medical and Genomma Lab Internacional Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America

RepublicWorld: Trial Of New Oral Drug Against COVID-19 Commences In South Africa

  • by

South Africa has been struggling with its plans to achieve herd immunity through vaccinations, with widespread vaccine hesitancy, largely fuelled by social media misinformation. Written ByPress Trust Of India Oravax Medical Inc, a subsidiary of US/Israeli pharmaceutical company Oramed, has started the first phase of the clinical trial… Read More »RepublicWorld: Trial Of New Oral Drug Against COVID-19 Commences In South Africa

Jerusalem Post: Israeli co. kicks off COVID oral vaccine trial in South Africa

  • by

Volunteers for Oramed’s medical trial will receive two doses of the oral COVID vaccine three weeks apart. By MAAYAN JAFFE-HOFFMAN Published: DECEMBER 14, 2021 16:07Updated: DECEMBER 14, 2021 17:47     Oramed Pharmaceuticals company.(photo credit: Judy Siegel-Itzkovich) The first volunteer in a Phase I clinical trial of an oral COVID-19 vaccine developed by an Israeli-American… Read More »Jerusalem Post: Israeli co. kicks off COVID oral vaccine trial in South Africa

Israel21c: Israeli oral COVID vaccine heads to Mexico, aims to fast-track approval

  • by

Oramed’s Oravax Medical and Genomma Lab Internacional announce joint venture to develop and commercialize vaccine for Latin America. By Abigail Klein Leichman  NOVEMBER 23, 2021, 10:56 AM Current Covid-19 vaccines are delivered via a shot in the arm – nobody’s favorite way to receive any medication – and must be… Read More »Israel21c: Israeli oral COVID vaccine heads to Mexico, aims to fast-track approval

Bloomberg: Oramed to Start Oral Covid-19 Vaccine Trial in South Africa

  • by

Oramed Pharmaceuticals Inc. won approval to run an initial clinical trial for its orally delivered Covid-19 vaccine candidate in South Africa. The U.S.-listed company has been given permission by the South African Health Regulatory Products Authority to start enrolling patients in Phase 1 of tests, it said in a… Read More »Bloomberg: Oramed to Start Oral Covid-19 Vaccine Trial in South Africa

Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial

  • by

NEW YORK, October 29, 2021 – Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that its majority-owned subsidiary, Oravax Medical Inc. (www.ora-vax.com), has received clearance from the South African Health Products Regulatory Authority to commence… Read More »Oramed Announces Oravax’s Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial

Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial

  • by

Oravax’s virus-like particle (VLP) vaccine being tested against COVID-19 variants including Delta  Oravax signs licensing deal for VLP injectable vaccine technology with Premas Biotech for commercialization in India  NEW YORK, July 21, 2021 – Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development… Read More »Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial

Gulf News: An oral COVID vaccine is nearly ready, will it help end the pandemic?

  • by

Washington/Dubai: Imagine a COVID-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes. Israeli pharmaceutical Oramed is attempting to accomplish just that, and is poised to start its first clinical trial in early August, CEO Nadav… Read More »Gulf News: An oral COVID vaccine is nearly ready, will it help end the pandemic?